Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Multiple Myeloma
Multiple Myeloma
Bluebird has a promising new update on its BCMA CAR-T for multiple myeloma, but is it still the leader?
Endpoints
Mon, 06/5/17 - 12:10 pm
Bluebird Bio
BCMA
CAR-T
Multiple Myeloma
ASCO 2017
bb2121
Celgene
Sanofi beefs up cancer drug pipeline, paying cash hungry ImmunoGen $30M for full rights to oncology portfolio
Endpoints
Tue, 05/30/17 - 10:40 am
Sanofi
Immunogen
oncology
M&A
isatuximab
Multiple Myeloma
Amgen Files Marketing Applications to Expand Xgeva's Use to US and EU MM Patients
Yahoo/GuruFocus
Mon, 04/10/17 - 10:02 am
Amgen
Xgeva
Multiple Myeloma
Europe
Karyopharm shakes off clinical hold for lead cancer med
BioPharma Dive
Fri, 03/31/17 - 11:00 am
Karyopharm
Selinexor
clinical trials
solid tumors
diffuse large B-cell lymphoma
Multiple Myeloma
Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study
Yahoo/Reuters
Tue, 02/28/17 - 11:12 am
Amgen
Kyprolis
Velcade
Takeda
Multiple Myeloma
Johnson & Johnson May Already Have Its Remicade Replacement Well in Hand
Motley Fool
Sat, 02/25/17 - 03:21 pm
JNJ
Remicade
Darzalex
Genmab
Multiple Myeloma
Inside Celgene’s Revlimid: Strong Patient Demand in 4Q16
Market Realist
Tue, 01/31/17 - 09:52 am
Celgene
Revlimid
Multiple Myeloma
Is This Johnson & Johnson's Next Billion-Dollar Blockbuster?
Motley Fool
Thu, 01/26/17 - 10:18 am
JNJ
Darzalex
Multiple Myeloma
Is Donald Trump Celgene's Biggest Risk in 2017?
Motley Fool
Tue, 01/17/17 - 10:23 pm
Celgene
Revlimid
drug pricing
Multiple Myeloma
Donald Trump
3 Biggest Risks for Celgene Corporation
Motley Fool
Thu, 12/15/16 - 06:44 pm
Celgene
Darzalex
Multiple Myeloma
Allergan
generics
Abraxane
Revlimid
Bluebird bio stock gains on impressive early cancer trial results
Bizjournals.com
Thu, 12/1/16 - 09:53 am
Bluebird Bio
clinical trials
bb2121
Multiple Myeloma
You'll Never Guess Who Owns the Most Spectacular New Cancer Drug
Motley Fool
Mon, 11/21/16 - 02:25 pm
JNJ
Darzalex
Multiple Myeloma
Powerful Dems orchestrated campaign at FDA to provide Biogen drug to a dying, high-profile fundraiser
Endpoints
Sun, 10/16/16 - 12:32 pm
FDA
Biogen
Multiple Myeloma
compassionate use guidelines
Celgene CEO: myeloma and glioblastoma both priorities
BioPharma Dive
Tue, 10/4/16 - 03:56 pm
Celgene
Multiple Myeloma
glioblastoma
marizomib
R&D
Amgen’s Backup Plan for Kyprolis (AMGN)
Investopedia
Sun, 10/2/16 - 10:22 am
Amgen
Kyprolis
Multiple Myeloma
Amgen's Kyprolis Fails To Met Endpoint, But It's Not All Bad News
Yahoo/Benzinga
Thu, 09/29/16 - 08:13 am
Amgen
Kyprolis
clinical trials
Multiple Myeloma
Amgen's multiple myeloma drug falls short in late stage study
Yahoo/Reuters
Tue, 09/27/16 - 10:18 am
Amgen
Multiple Myeloma
Kyprolis
clinical trials
Takeda
Velcade
Karyopharm sets a course for the FDA with positive PhIIb multiple myeloma data
Endpoints
Tue, 09/6/16 - 10:56 am
Karyopharm
FDA
clinical trials
Multiple Myeloma
Selinexor
3 Clinical-Stage Biotech Stocks With News About To Break
Motley Fool
Thu, 09/1/16 - 09:30 am
Novavax
RSV F vaccine
Agile Therapeutics
birth control patch
Twirla
Karyopharm
Selinexor
Multiple Myeloma
Juno Throws Down The Multiple Myeloma Gauntlet To Bluebird
Seeking Alpha
Tue, 08/9/16 - 10:54 pm
Juno Therapeutics
Multiple Myeloma
Bluebird Bio
CAR-T
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »